CervoMed Inc. Current Liabilities
CervoMed Inc. (CRVO) had Current Liabilities of $4.66 million as of 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-03-13
- 2025-12-31: Liabilities, Current $4.66M.
- 2024-12-31: Liabilities, Current $3.88M.
- 2022-09-30: Liabilities, Current $2.27M.
- 2022-06-30: Liabilities, Current $2.52M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $4.66M 10-K · filed 2026-03-13 | |
| 2024-12-31 | $3.88M 10-K · filed 2026-03-13 | |
| 2022-09-30 | $2.27M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.52M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $2.96M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.93M 10-Q · filed 2022-11-14 | |
| 2021-09-30 | $2.75M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $2.10M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $2.11M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $2.44M 10-K · filed 2022-03-18 | |
| 2020-09-30 | $2.69M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.78M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $1.29M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.72M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $1.22M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $1.04M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.19M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $804.04K 10-K · filed 2020-03-17 | |
| 2018-09-30 | $945.68K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $688.02K 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $1.42M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.69M 10-K · filed 2019-03-19 | |
| 2017-09-30 | $18.69M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $29.46M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $51.60M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $4.44M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $3.68M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.76M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $2.21M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $1.47M 10-K · filed 2017-03-31 | $1.20M 10-K · filed 2016-03-25 |
| 2015-09-30 | $2.03M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $2.57M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $2.09M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $2.34M 10-K · filed 2016-03-25 | |
| 2014-09-30 | $2.98M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $4.13M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $10.69M 10-Q · filed 2014-05-20 | |
| 2013-12-31 | $8.88M 10-K · filed 2015-04-03 | |
| 2013-09-30 | $9.57M 10-Q · filed 2013-11-19 | |
| 2013-06-30 | $8.77M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $21.92M 10-Q/A · filed 2013-05-20 | |
| 2012-12-31 | $20.85M 10-K/A · filed 2014-04-23 | |
| 2012-09-30 | $9.98M 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $8.78M 10-Q/A · filed 2012-09-07 | |
| 2011-12-31 | $19.68M 10-K/A · filed 2013-04-24 | $3.79M 10-K · filed 2012-05-21 |
| 2011-09-30 | $3.34M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $3.19M 10-Q · filed 2011-08-16 | |
| 2010-12-31 | $4.93M 10-K · filed 2012-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |